Treatment(s) already received-Immunotherapy Posts on Medivizor
Navigation Menu

Treatment(s) already received-Immunotherapy Posts on Medivizor

What types of skin-related side effects do biological treatments cause in patients with melanoma?

Posted by on Apr 3, 2020 in Melanoma | 0 comments

In a nutshell This article reviewed the types and frequency of different skin-related side effects that patients with melanoma experience while receiving biological treatments. Some background Treatment for patients with melanoma has changed in recent years from chemotherapy to biological therapies. Biological therapies include BRAF inhibitors...

Read More

Association of side effects and response to treatment in patients with melanoma treated with nivolumab

Posted by on Dec 27, 2018 in Melanoma | 0 comments

In a nutshell This study wanted to find out if patients with melanoma who had immune system side effects after treatment with nivolumab (Opdivo) had better outcomes than patients without side effects. The study found that the patients who had side effects from using nivolumab ended up with better responses to treatment and...

Read More

Can S100B and lactate dehydrogenase (LDH) levels be used to predict survival in patients with melanoma?

Posted by on Aug 3, 2018 in Melanoma | 0 comments

In a nutshell This study investigated whether levels of S100B and lactate dehydrogenase (LDH) in patients with melanoma treated with immunotherapy has any relationship to survival. The study found that increased levels of S100B and LDH were associated with reduced survival in patients with melanoma treated with certain immunotherapies. Some background...

Read More

Have targeted therapies improved the survival of patients with melanoma brain metastases

Posted by on Jun 28, 2018 in Melanoma | 0 comments

In a nutshell This study investigated whether the risk of developing melanoma brain metastases (MBM) and survival among patients with MBM has changed since the introduction of more effective therapies. The results found the overall survival for patients with MBM has improved significantly since 2011. Some background In more than 33% of patients...

Read More

Nivolumab treatment is associated with an improved survival in advanced melanoma

Posted by on Oct 16, 2017 in Melanoma | 0 comments

In a nutshell This study investigated the effect of nivolumab (Opdivo) in patients with progressive melanoma after ipilimumab (Yervoy) treatment. Researchers suggested that nivolumab treatment is associated with better response compared with chemotherapy. Some background Recent new therapies, such as immunotherapy, have changed the treatment of...

Read More

Ipilimumab-induced hypophysitis in advanced melanoma

Posted by on Oct 11, 2015 in Melanoma | 0 comments

In a nutshell The authors analyzed the occurrence, management and risk factors of hypophysitis (a complication of the immune system following ipilimumab [Yervoy] therapy) in advanced melanoma patients.   Some background In advanced melanoma (stage III/IV), cancer spreads rapidly from the skin to other parts of the body....

Read More

Immunotherapy in advanced melanoma: a review

Posted by on Aug 30, 2015 in Melanoma | 0 comments

In a nutshell The authors reviewed different immunotherapies for advanced melanoma.  Some background In advanced melanoma (stage III/IV), cancer spreads from the skin to other parts of the body. Immunotherapy is a common treatment used in advanced melanoma. It uses the body’s own immune system to fight cancer. This...

Read More